These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34792596)

  • 1. Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials.
    Ramachandran R; Ross JS; Miller JE
    JAMA Netw Open; 2021 Nov; 4(11):e2134233. PubMed ID: 34792596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A matter of priority: equitable access to COVID-19 vaccines.
    Holzer F; Luna F; Manriquez T; Biller-Andorno N
    Swiss Med Wkly; 2021 Mar; 151():w20488. PubMed ID: 33715145
    [No Abstract]   [Full Text] [Related]  

  • 4. Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward.
    Aborode AT; Olofinsao OA; Osmond E; Batubo AP; Fayemiro O; Sherifdeen O; Muraina L; Obadawo BS; Ahmad S; Fajemisin EA
    J Med Virol; 2021 Sep; 93(9):5212-5215. PubMed ID: 34009657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to COVID-19 vaccines: looking beyond COVAX.
    The Lancet
    Lancet; 2021 Mar; 397(10278):941. PubMed ID: 33714374
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members
    Lancet; 2021 Feb; 397(10274):562-564. PubMed ID: 33516284
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 vaccines for low- and middle-income countries.
    Choi EM
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):447-456. PubMed ID: 33733663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
    Padma TV
    Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccine equity and booster doses.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Sep; 21(9):1193. PubMed ID: 34391506
    [No Abstract]   [Full Text] [Related]  

  • 11. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan.
    Adejumo OA; Adejumo OA
    Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
    Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
    [No Abstract]   [Full Text] [Related]  

  • 13. Ensure Palestinians have access to COVID-19 vaccines.
    Martin S; Arawi T
    Lancet; 2021 Feb; 397(10276):791-792. PubMed ID: 33577758
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Vaccine Global Access Is an Urgency.
    Negahdaripour M
    Iran J Med Sci; 2021 Mar; 46(2):79-80. PubMed ID: 33753951
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in the rollout of COVID-19 vaccines worldwide.
    Burki TK
    Lancet Respir Med; 2021 Apr; 9(4):e42-e43. PubMed ID: 33684355
    [No Abstract]   [Full Text] [Related]  

  • 16. It's time to consider a patent reprieve for COVID vaccines.
    Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920
    [No Abstract]   [Full Text] [Related]  

  • 17. Could human challenge studies for COVID-19 vaccines be justified in South Africa?
    Moodley K; Maasdorp E; Rennie S
    S Afr Med J; 2021 Mar; 111(6):559-562. PubMed ID: 34382566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End COVID-19 in low- and middle-income countries.
    Mobarak AM; Miguel E; Abaluck J; Ahuja A; Alsan M; Banerjee A; Breza E; Chandrasekhar AG; Duflo E; Dzansi J; Garrett D; Goldsmith-Pinkham P; Gonsalves GS; Hossain MM; Jakubowski A; Kang G; Kharel A; Kremer M; Meriggi N; Nekesa C; Olken BA; Omer SB; Qadri F; Rees H; Salako B; Voors M; Warren S; Więcek W
    Science; 2022 Mar; 375(6585):1105-1110. PubMed ID: 35271319
    [No Abstract]   [Full Text] [Related]  

  • 19. Just allocation of COVID-19 vaccines.
    Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
    [No Abstract]   [Full Text] [Related]  

  • 20. Embedding global access in development of future pandemic vaccines.
    Moon S; Agarwal S; Becker A; Alonso Ruiz A
    BMJ; 2021 Sep; 374():n2256. PubMed ID: 34544796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.